docj, I would be acutely interested in what response you receive from the guy at Barron's. Obviously, before he makes any decision to write anything about a company, he will conduct some DD, as I expect he (like many other writers for financial mags) receive requests, "hot tips," and the like, regularly. If he decides against running anything about the company, there would be a reason, and if he favors you with a response either way, it would be an educating read, I expect.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links